PD risk associated with GBA1 variants has been attributed to the toxic effects of misfolded glucocerebrosidase (GCase) (gain-of-function)17–20, and/or the accumulation of lipid substrates due to reduced enzyme activity (loss-of-function)21–23. This evidence concerns the gene GBA1 and Parkinson disease.